Test Writing Basics
Release date: October 30, 2019
Expiration date: October 30, 2022
ACPE credit must be claimed by: October 30, 2022
Offered On-Demand only.
This webinar will address basic considerations appropriate for the construction of test questions for classroom and webinar contexts, and will briefly discuss differences with credentialing examinations. The idea of a Test Blueprint will be introduced, as well as a comparison of the Test Blueprint vs Learning Objectives. Examples of how questions can include the hierarchical components of the Bloom's taxonomy are given, as well as guidance on how to avoid some common mistakes when writing multiple choice questions. In addition, examples of item analyses of good and poor test items will be presented and discussed to illustrate how these tools can be used to retrospectively improve the reliability and validity of tests.
- Explain the nature and purpose of a Test Blueprint
- Contrast the differences between Learning Objectives and a Test Blueprint
- Describe the levels of Bloom’s taxonomy
- Describe common mistakes made in preparing multiple choice examination questions
- Describe how to interpret and respond to item analysis of questions
Paul Hutson is a Professor of Pharmacy Practice at the University of Wisconsin School of Pharmacy in Madison. He practices pharmacy with the oncology and palliative care teams at the UW Hospital and Clinics and is an Associate Member of the UW Carbone Cancer Center. He was the Principal Investigator for the recent Phase I dose escalation and pharmacokinetic study of psilocybin in healthy adults performed at the UW, and is a co-investigator for the Phase III study of MDMA for PTSD. His course offerings at the UW School of Pharmacy are Clinical Pharmacokinetics, Pediatric Pharmacotherapy, Appropriate use of Drugs of Abuse, and Oncology.
Professor Hutson has served as the Chair of two Data Monitoring Committees overseeing two NIH RO1-funded clinical studies, and currently serves as a member of the UW ICTR DMC. He served for 20 years on the UW GCRC/ICTR protocol scientific review committee, and for 12 years on the UWCCC Protocol Review and Monitoring Committee.
This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-19-076-H04-P.
HOPA Member ‒ $20
Nonmember ‒ $40
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test. ACPE credit must be claimed by October 30, 2022.
Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.